Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer

Yosuke Harada1, Mitsugu Kanehira, Yoshiko Fujisawa

  • 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Cancer Research
|July 1, 2010
PubMed

Insights

Researchers identified a critical interaction between DEPDC1 and ZNF224 in bladder cancer. Inhibiting this complex with a peptide therapy induced cancer cell death by activating A20 and suppressing NF-kappaB signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Bladder cancer is a prevalent genitourinary malignancy with incompletely understood oncogenic drivers.
  • The cancer-testis antigen DEP domain-containing protein 1 (DEPDC1) has emerged as a potential contributor to bladder cancer development.

Purpose of the Study:

  • To elucidate the biological functions of DEPDC1 in bladder cancer.
  • To define a novel therapeutic strategy targeting DEPDC1.

Main Methods:

  • Coimmunoprecipitation and immunocytochemistry were employed to investigate protein interactions.
  • Cell-permeable peptides were designed to inhibit specific protein-protein interactions.
  • In vitro and in vivo assays were conducted to assess therapeutic efficacy.

Main Results:

  • DEPDC1 was found to interact and colocalize with the transcriptional repressor zinc finger protein 224 (ZNF224).
  • A cell-permeable peptide targeting the DEPDC1-ZNF224 interaction induced apoptosis in bladder cancer cells.
  • This inhibition led to the transcriptional activation of A20, a negative regulator of the NF-kappaB pathway.

Conclusions:

  • The DEPDC1-ZNF224 complex plays a significant role in bladder cancer progression.
  • Targeting this complex represents a promising therapeutic avenue for bladder cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...